Advertisement Onset Therapeutics launches topical anesthetic - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Onset Therapeutics launches topical anesthetic

Onset Therapeutics has announced that the patients can purchase Anestafoam on-line through www.dermadoctor.com. Anestafoam, a novel topical foam formulation containing lidocaine 4%, is said to be the first and only foam formulation of lidocaine on the market.

Anestafoam is indicated for the temporary relief of pain associated with minor cuts and scrapes, abrasions, skin irritation, sunburn, burns and insect bites, and it incorporates the company’s proprietary Delevo Foam Technology, which utilizes a semi-solid emollient micro-emulsion system to deliver the active ingredient rapidly and efficiently.

Anestafoam is also available for patient purchase through retail drug stores and dispensing dermatologists. Dermatologists can purchase Anestafoam directly from the manufacturer or through a distributor.

Mary Theriault, director of marketing of Onset Therapeutics, said: “In addition to the option of dispensing out of the dermatology practice and the traditional stocking at local retail pharmacies, on-line distribution channels offer patients the flexibility of purchasing Anestafoam from the comfort of their own home.”